Screening Mammography: Single Reading by One Radiologist With AI vs. Double Reading by Two Radiologists (AI-BCSQ)
Recruiting
N/A
Interventional Study
Breast Cancer Screening
Artificial Intelligence (AI)
Breast Cancer Screening and Diagnosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 45 – 69
- Sex
- Female
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 8,000 (estimated)
- Sponsor
- University Hospital Olomouc · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A randomized prospective study comparing the evaluation of mammography images in a breast cancer screening programme by a single radiologist with AI support versus standard double reading by two radiologists without AI support.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age 45-69, asymptomatic woman participating in breast cancer screening programme
Exclusion Criteria:
* clinical signs of breast disease - indication for diagnostic mammography
Contacts